ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
DMRC
Digimarc Corporation
There isn't enough reported data to score DMRC yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
DMRC Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Unavailable |
DMRC's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
DMRC PE Valuation
DMRC has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
DMRC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Stable | |
| -- | |
| Limited | |
| High |
Analysts expect DMRC's earnings, revenue and profitability to hold roughly steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
DMRC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.42 | +$0.41 |
| Q1 2026 | -$1.26 | +$0.62 |
| Q4 2025 | -$1.49 | +$0.34 |
| Q3 2025 | -$1.71 | +$0.22 |
| Q2 2025 | -$1.83 | +$0.13 |
| Q1 2025 | -$1.88 | +$0.18 |
| Q4 2024 | -$1.83 | +$0.43 |
| Q3 2024 | -$1.93 | +$0.41 |
DMRC has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over DMRC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
DMRC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $7.4M | -7.8% |
| Q1 2026 | $7.6M | -19% |
| Q4 2025 | $8.9M | +2.9% |
| Q3 2025 | $7.6M | -19% |
| Q2 2025 | $8M | -23% |
| Q1 2025 | $9.4M | -5.7% |
| Q4 2024 | $8.7M | -6.7% |
| Q3 2024 | $9.4M | +5% |
DMRC's revenue has slid since its 2024 peak: $7M last quarter, down 7.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -167% | -62 points |
| Q1 2026 | -94% | +35 points |
| Q4 2025 | -48% | +57 points |
| Q3 2025 | -110% | +11 points |
| Q2 2025 | -105% | -9 points |
| Q1 2025 | -129% | -20 points |
| Q4 2024 | -105% | +14 points |
| Q3 2024 | -120% | +3.6 points |
DMRC has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
DMRC has the stronger cash trend. Its trailing FCF is up 68% versus its history, compared with ASTS at down 363%.
DMRC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$1.9M | +$3.7M |
| Q4 2025 | $895K | +$5.1M |
| Q3 2025 | -$2.8M | +$4.3M |
| Q2 2025 | -$4.9M | +$2M |
| Q1 2025 | -$5.5M | +$3M |
| Q4 2024 | -$4.2M | +$1.2M |
| Q3 2024 | -$7.2M | -$6.9M |
| Q2 2024 | -$6.9M | +$960K |
DMRC has burned cash in almost every quarter: −$9M over the past year, against −$24M the year before.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
DMRC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +260K shares |
| 1 year | +3.1% | +660K shares |
| 3 years | +10% | +2.1M shares |
| 5 years | +36% | +5.8M shares |
| Available history | +87% | +10.3M shares |
DMRC has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2026 | $885,000 |
| Q4 2025 | $412,000 |
| Q3 2025 | $419,000 |
| Q2 2025 | $503,000 |
| Q1 2025 | $1.5M |
| Q4 2024 | $526,000 |
| Q3 2024 | $558,000 |
| Q2 2024 | $551,000 |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DMRC Net Leverage
DMRC's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
DMRC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.2 | Neutral |
| Stochastic | 74.1 | Neutral |
DMRC's weekly RSI is 51 (neutral) and its Stochastic is 74 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
DMRC PE vs Technology Sector
DMRC has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
DMRC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.93 | 7.2% above |
| 20 week MA | $6.57 | 13% above |
| 50 week MA | $7.20 | 3.2% above |
| 100 week MA | $11.9 | 38% below |
| 200 week MA | $20.4 | 64% below |
DMRC has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
DMRC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $33.1 | $50.8 | +53% |
| 2021 | $50.8 | $42.9 | -15% |
| 2022 | $42.9 | $18.9 | -56% |
| 2023 | $18.9 | $36.1 | +92% |
| 2024 | $36.1 | $38.0 | +5.2% |
| 2025 | $38.0 | $6.83 | -82% |
| 2026 YTD | $6.83 | $7.43 | +8.8% |
DMRC has the edge over ASTS on returns for 2026, with the stronger performance.